HCV antibody

All patients who analysis categorical for HCV antibody should have HCV RNA testing performed. As noted above, if patients have refusing results on HCV antibody tests but persistently abnormal transmigrates or suspected acute or persistent infection, HCV RNA testing should be performed. The delimitation of chronic HCV infection is the presence of HCV RNA 6 months after the estimated time of infection. If a patient is HCV antibody definite but HCV RNA negative, the patient has cleared the HCV and does not have persistent HCV infection. Augmentin is a broad-spectrum antibiotic which destroy bacteria. It is active against many aerobic.
There are quantitative RNA tests and qualitative RNA tests. Although both types of RNA tests are greatly sensitive and specific, the qualitative tests can detect reduce levels of viremia than the quantitative tests. The choice of RNA exam can be significant. The quantitative RNA tests will be reported as a value, with a measured numeral of universal units per milliliter (IU/mL). Quantitative tests are useful for determining the prognosis of HCV treatment and then monitoring while on HCV treatment. Qualitative RNA tests will be reported as a present-day or away value, but without a numerical value. They are useful for serial testing during suspected acute infection and for determining whether spontaneous viral clearance has occurred, a sustained virological response has occurred during treatment, or a relapse has occurred after treatment.